Commit To Purchase Berkshire Hathaway At $340, Earn 1.6% Using Options

At a current BRK.B price of $508.05, selling the January 2028 $340 put would yield a $5.55 premium (implying a $334.45 effective cost basis if exercised) and only provide a 0.8% annualized return unless shares fall ~33.1% and the contract is assigned. Trailing 12-month volatility is calculated at 19%, and the piece frames the trade as a low-yield, downside-risk strategy useful for option sellers who are comfortable acquiring shares at a large discount but otherwise only collecting a modest premium.

Analysis

Market structure: The quoted Jan‑2028 BRK.B $340 put (0.8% annualized) benefits short‑dated income seekers and exchanges/clearing firms (NDAQ) collecting flow, while long‑term downside protection buyers receive little cover for fat‑tail events. With BRK.B at $508.05 and trailing vol ~19%, the $340 strike sits ~33% OTM — low probability but high impact if assigned; demand for safe yield is driving put supply, compressing option carry versus realized variance.

Risk assessment: Tail risks are a >33% market/securities shock (macro recession, large Berkshire writedowns, succession crisis) that would convert tiny premium into full equity exposure at $334.45/share and generate immediate mark‑to‑market losses; counterparty/exercise timing (American puts) and margin rules can force liquidity needs. In days-to-weeks, IV and margin moves matter most; over quarters/years Berkshire’s fundamentals likely reassert, but capital lock‑up and opportunity cost persist.

Trade implications: Avoid writing naked Jan‑2028 $340 puts for 0.8% annualized unless you truly want to own BRK.B at $334.45. Prefer structured income: sell 12–36 month put spreads to cap tail risk, or buy WRAP (buy shares + sell 3–6 month 8–12% OTM calls) to harvest yield; opportunistically sell shorter‑dated 3–9 month cash‑secured puts 20–30% OTM when IV spikes above 25% for target 3–6% annualized.

Contrarian angle: The market is underpricing long‑dated tail exposure — 19% realized vol vs tiny premium signals asymmetry. Historical parallels (2008) show modest long‑dated premia evaporate in crises; mispricing favors defined‑risk sellers (credit spreads) or willing buyers of BRK.B equity at deep discounts rather than naked insurance sellers who face large capital drawdowns.

Key Decisions for Investors

• Do NOT sell naked BRK.B Jan‑2028 $340 puts for 0.8% annualized unless you want to own BRK.B at $334.45; instead limit naked exposure to ≤1% NAV and only if you have capital to absorb a >33% drawdown.
• Sell a defined‑risk Jan‑2028 BRK.B bull put spread (sell 340 / buy 240) to collect credit while capping max loss at ~$100/share minus credit; size at 1–2% NAV per spread to harvest premium without open‑ended tail risk.
• Establish a 2–3% long position in BRK.B via buy‑write: buy shares and sell 3–6 month calls 8–12% OTM (roll or unwind after 6–12 months); target incremental yield 3–6% while retaining long exposure.
• If yield hunting, sell 3–9 month cash‑secured BRK.B puts 20–30% OTM (e.g., ~$380–$400 strike) sized 1–3% NAV, but only execute when IV >25% and be prepared to buy at strike; hedge macro with 3‑month SPX puts or buy BRK.B protective puts if assigned.